+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Koninklijke Philips NV (PHIA) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 87 Pages
  • May 2024
  • GlobalData
  • Philips N.V.
  • ID: 2782630
Koninklijke Philips NV (PHIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Koninklijke Philips NV (Philips) is a diversified technology company that develops and manufactures medical systems and consumer electronics products. The company offers products and solutions in the areas of diagnostic imaging, enterprise diagnostic informatics, image-guided therapy, ultrasound, monitoring and analytics, sleep and respiratory care, population health management, connected care informatics, and therapeutic care. It offers mother and childcare, personal care and oral healthcare products, including power toothbrushes, brush heads, baby bottles, sterilizers, breast pumps, shavers, groomers, trimmers, skin care, hair care and hair removal products. The company has business presence across North America, Europe and Asia-Pacific. Philips is headquartered in Eindhoven, North Brabant, the Netherlands.

Koninklijke Philips NV Key Recent Developments

  • May 02, 2024: Radboud University Medical Center and Philips sign 10-year patient monitoring partnership and agreement to keep software state-of-the-art
  • Apr 10, 2024: Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward
  • Apr 04, 2024: Philips Foundation and March of Dimes partner to improve prenatal care access in underserved communities, helping address US maternal and infant health challenges
  • Mar 22, 2024: Philips convenes the Annual General Meeting of Shareholders 2024

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Koninklijke Philips NV - Key Facts
  • Koninklijke Philips NV - Key Employees
  • Koninklijke Philips NV - Key Employee Biographies
  • Koninklijke Philips NV - Major Products and Services
  • Koninklijke Philips NV - History
  • Koninklijke Philips NV - Company Statement
  • Koninklijke Philips NV - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • Koninklijke Philips NV - Business Description
  • Business Segment: Connected Care
  • Overview
  • Performance
  • Business Segment: Diagnosis & Treatment
  • Overview
  • Performance
  • Business Segment: Other
  • Overview
  • Performance
  • Business Segment: Personal Health
  • Overview
  • Performance
  • Geographical Segment: Growth Geographies
  • Performance
  • Geographical Segment: North America
  • Performance
  • Geographical Segment: Other Mature Geographies
  • Performance
  • Geographical Segment: Western Europe
  • Performance
  • R&D Overview
  • Koninklijke Philips NV - Corporate Strategy
  • Koninklijke Philips NV - SWOT Analysis
  • SWOT Analysis - Overview
  • Koninklijke Philips NV - Strengths
  • Koninklijke Philips NV - Weaknesses
  • Koninklijke Philips NV - Opportunities
  • Koninklijke Philips NV - Threats
  • Koninklijke Philips NV - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences, Power Financial Deals and Alliances
  • Koninklijke Philips NV, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Koninklijke Philips NV, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Koninklijke Philips NV, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 02, 2024: Radboud University Medical Center and Philips sign 10-year patient monitoring partnership and agreement to keep software state-of-the-art
  • Apr 10, 2024: Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward
  • Apr 04, 2024: Philips Foundation and March of Dimes partner to improve prenatal care access in underserved communities, helping address US maternal and infant health challenges
  • Mar 22, 2024: Philips convenes the Annual General Meeting of Shareholders 2024
  • Mar 21, 2024: Philips Panel Discussion at HIMSS24 Focuses on the Role of Predictive and Generative AI in Addressing Critical Healthcare Challenges
  • Mar 20, 2024: Meet Carla Goulart Peron, Philips’ Chief Medical Officer
  • Mar 19, 2024: Leading in Health Technology Innovation: Philips One of the Top Patent Applicants at European Patent Office
  • Feb 28, 2024: Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)
  • Feb 20, 2024: Philips publishes its Annual Report 2023
  • Feb 20, 2024: Philips proposes to re-appoint Chairman Feike Sijbesma and Peter Löscher and nominates Benoît Ribadeau-Dumas as member of the Supervisory Board
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Koninklijke Philips NV, Key Facts
  • Koninklijke Philips NV, Key Employees
  • Koninklijke Philips NV, Key Employee Biographies
  • Koninklijke Philips NV, Major Products and Services
  • Koninklijke Philips NV, History
  • Koninklijke Philips NV, Other Locations
  • Koninklijke Philips NV, Subsidiaries
  • Koninklijke Philips NV, Joint Venture
  • Koninklijke Philips NV, Key Competitors
  • Koninklijke Philips NV, Ratios based on current share price
  • Koninklijke Philips NV, Annual Ratios
  • Koninklijke Philips NV, Interim Ratios
  • Koninklijke Philips NV, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Koninklijke Philips NV, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Koninklijke Philips NV, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Koninklijke Philips NV, Performance Chart (2019 - 2023)
  • Koninklijke Philips NV, Ratio Charts
  • Koninklijke Philips NV, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Koninklijke Philips NV, Medical Equipment, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Siemens Healthineers AG
  • Hologic Inc
  • Guerbet SA
  • GE HealthCare Technologies Inc
  • Canon Inc
  • Bruker Corp